Enanta Pharmaceuticals ENTA
NASDAQ ENTA
$12.64 +0.03 (+0.20%)
At close: Sep 29, 2026 · 4:00 PM EDT

Enanta Pharmaceuticals (ENTA) Operating Leases (2019 - 2026)

Updated

Enanta Pharmaceuticals' Operating Leases came in at $51.75 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 7.0% from $55.66 million a year earlier and down 1.9% from the prior quarter.

Analysis

Enanta Pharmaceuticals (ENTA) Operating Leases (2019 - 2026) Analysis & Trends

At the end of FY2025 (ended Sep 30, 2025), Enanta Pharmaceuticals' Operating Leases was $54.76 million, up 1.5% from FY2024.

  • Operating Leases carries a five-year compound annual growth rate of 70.2% (FY2020 to FY2025).
  • Going back by fiscal year, Operating Leases was $53.94 million in FY2024 (+154.0%), $21.24 million in FY2023 (-5.1%), $22.37 million in FY2022 and $1.13 million in FY2021 (-70.7%).
  • The fiscal Q3 2026 figure represents the lowest quarterly Operating Leases since fiscal Q3 2024.
  • Year-over-year, Operating Leases has declined for three consecutive quarters, with growth averaging 44.8% over the last eight quarters.
  • The fastest year-over-year change in Operating Leases over five years came in fiscal Q2 2022 (growth of 471.7%), and the weakest in fiscal Q4 2021 (a decline of 70.7%).
  • Business Quant data shows ENTA's Operating Leases at $52.78 million (Q2 2026), $53.78 million (Q1 2026) and $54.76 million (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Enanta Pharmaceuticals 367.20 Mn -360.79 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 51.75 Mn
Mar 31, 2026 52.78 Mn
Dec 31, 2025 53.78 Mn
Sep 30, 2025 54.76 Mn
Jun 30, 2025 55.66 Mn
Mar 31, 2025 56.54 Mn
Dec 31, 2024 56.45 Mn
Sep 30, 2024 53.94 Mn
Jun 30, 2024 48.14 Mn
Mar 31, 2024 43.41 Mn
Dec 31, 2023 20.52 Mn
Sep 30, 2023 21.24 Mn
Jun 30, 2023 22.33 Mn
Mar 31, 2023 23.07 Mn
Dec 31, 2022 21.86 Mn
Sep 30, 2022 22.37 Mn
Jun 30, 2022 22.21 Mn
Mar 31, 2022 15.12 Mn
Dec 31, 2021 15.96 Mn
Sep 30, 2021 1.13 Mn
API Access

Enanta Pharmaceuticals Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=ENTA&period=max&api_key=YOUR_API_KEY